VERVE THERAPEUTICS INC's ticker is VERV and the CUSIP is 92539P101. A total of 137 filers reported holding VERVE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.34 and the average weighting 0.3%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 2,008,809 | $26,636,807 | 17.30% |
| Alphabet Inc. | 10,549,086 | $139,880,880 | 8.98% |
| Casdin Capital, LLC | 2,954,710 | $39,179,455 | 4.34% |
| MPM BioImpact LLC | 857,940 | $11,376,284 | 3.04% |
| Saltoro Capital, LP | 66,500 | $881,790 | 0.79% |
| ARK Investment Management | 5,200,567 | $68,959,525 | 0.53% |
| Redmile Group, LLC | 809,777 | $10,737,643 | 0.51% |
| Ikarian Capital, LLC | 2,413 | $3,199,638 | 0.38% |
| Logos Global Management LP | 215,000 | $2,850,900 | 0.38% |
| Nikko Asset Management Americas, Inc. | 2,147,243 | $28,429,497 | 0.34% |
| Ikarian Capital, LLC | 2,000 | $2,652,000 | 0.32% |
| Cormorant Asset Management, LP | 350,000 | $4,641,000 | 0.27% |
| Green Alpha Advisors, LLC | 24,625 | $326,527 | 0.25% |
| BVF INC/IL | 650,000 | $8,619,000 | 0.23% |
| Artal Group S.A. | 300,000 | $3,978 | 0.17% |
| Avidity Partners Management LP | 285,334 | $3,783,529 | 0.15% |
| WADE G W & INC | 259,626 | $3,443 | 0.13% |
| Baker Brothers Advisors | 1,416,530 | $18,783,188 | 0.11% |
| FEDERATED HERMES, INC. | 2,532,369 | $33,579,213 | 0.09% |
| Woodline Partners LP | 521,260 | $6,911,908 | 0.08% |
External links
This page lists VERVE THERAPEUTICS INC's shareholders in Q3 2023. To view VERVE THERAPEUTICS INC's shareholder history, click here.